SPI Extra
5.700,32
PKT
-38,36
PKT
-0,67
%
Werbung
Analysen zu SPI Extra-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.02.12 | Schindler neutral | UBS AG | |
| 24.02.12 | BB Biotech halten | Independent Research GmbH | |
| 28.02.12 | Allreal neutral | Sarasin Research | |
| 23.02.12 | Sulzer buy | Sarasin Research | |
| 22.02.12 | Straumann neutral | Sarasin Research | |
| 21.02.12 | Schindler buy | Sarasin Research | |
| 21.02.12 | Swatch (I) buy | Deutsche Bank AG | |
| 21.02.12 | Julius Bär buy | Sarasin Research | |
| 20.02.12 | Clariant buy | Citigroup Corp. | |
| 17.02.12 | EMS-CHEMIE buy | Sarasin Research | |
| 17.02.12 | BB Biotech kaufen | Hanseatischer Börsendienst | |
| 17.02.12 | Swatch (I) buy | Sarasin Research | |
| 16.02.12 | Clariant overweight | Barclays Capital | |
| 16.02.12 | Vontobel reduce | Sarasin Research | |
| 16.02.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 15.02.12 | Sankt Galler Kantonalbank (N) neutral | Sarasin Research | |
| 15.02.12 | Clariant buy | Sarasin Research | |
| 14.02.12 | Emmi neutral | Sarasin Research | |
| 13.02.12 | Tecan (N) neutral | Sarasin Research | |
| 09.02.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 09.02.12 | Swatch (I) kaufen | Focus Money | |
| 08.02.12 | Swatch (I) buy | Société Générale Group S.A. (SG) | |
| 08.02.12 | Swatch (I) buy | Sarasin Research | |
| 08.02.12 | Swatch (I) buy | Nomura | |
| 07.02.12 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 07.02.12 | Swatch (I) kaufen | Sarasin Research | |
| 07.02.12 | Julius Bär buy | Sarasin Research | |
| 06.02.12 | BB Biotech kaufen | Euro am Sonntag | |
| 03.02.12 | Bucher Industries neutral | UBS AG | |
| 03.02.12 | Logitech neutral | Sarasin Research | |
| 02.02.12 | Rieter neutral | Sarasin Research | |
| 02.02.12 | Emmi neutral | Sarasin Research | |
| 02.02.12 | Bucher Industries neutral | Sarasin Research | |
| 02.02.12 | BB Biotech verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 01.02.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 01.02.12 | Vontobel underperform | Cheuvreux SA | |
| 01.02.12 | EFG International outperform | Cheuvreux SA | |
| 01.02.12 | BB Biotech halten | Independent Research GmbH | |
| 30.01.12 | Sulzer kaufen | Die Actien-Börse | |
| 30.01.12 | OC Oerlikon kaufen | Die Actien-Börse |